Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis
Open Access
- 1 November 2005
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 76 (11), 1544-1549
- https://doi.org/10.1136/jnnp.2004.049676
Abstract
Objective: Herpes simplex virus encephalitis (HSVE) is associated with significant morbidity and mortality, even with appropriate antiviral therapy. In the present investigation, the first to assess efficacy of corticosteroid treatment with aciclovir therapy in HSVE, multiple logistic regression analysis was performed of predictors of outcome in adult patients with HSVE. Methods: A non-randomised retrospective study of 45 patients with HSVE treated with aciclovir was conducted. The patients were divided into poor and good groups based on outcome at three months after completion of aciclovir treatment. The variables evaluated were: clinical variables (sex, age, days after onset at initiation of aciclovir, Glasgow Coma Scale (GCS) at initiation of aciclovir, initial and maximum values for the cell numbers and protein concentration in the cerebrospinal fluid, and corticosteroid administration); neuroradiological variables (detection of lesions by initial cranial computed tomography and by initial magnetic resonance imaging); and one neurophysiological variable (detection of periodic lateralised epileptiform discharges on the initial electroencephalogram). Single variable logistic regression analysis was performed followed by multiple logistic regression analysis. The best set of predictors for the outcome of HSVE was estimated by stepwise logistic regression analysis. Results: A poor outcome was evident with older age, lower GCS score at initiation of aciclovir, and no administration of corticosteroid. Patient age, GCS at initiation of aciclovir, and corticosteroid administration were found to be significant independent predictors of outcome on multiple logistic regression analysis, and these three variables also formed the best set of predictors (R2 = 0.594, pConclusion: Combination therapy using both aciclovir and corticosteroid represents one of the predictors of outcome in HSVE.Keywords
This publication has 12 references indexed in Scilit:
- Experimental Herpes Simplex Virus Encephalitis: A Combination Therapy of Acyclovir and Glucocorticoids Reduces Long-Term Magnetic Resonance Imaging AbnormalitiesJournal of NeuroVirology, 2003
- Outcome of and Prognostic Factors for Herpes Simplex Encephalitis in Adult Patients: Results of a Multicenter StudyClinical Infectious Diseases, 2002
- Direct and mononuclear cell mediated effects on interleukin 6 production by glioma cells in infection with herpes simplex virus type 1Journal of Medical Virology, 2001
- Role of clinical, radiological, and neurophysiological changes in predicting the outcome of tuberculous meningitis: a multivariable analysisJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Herpes simplex replication and dissemination is not increased by corticosteroid treatment in a rat model of focal Herpes encephalitisJournal of NeuroVirology, 2000
- Comparative study between chemiluminescence assay and two different sensitive polymerase chain reactions on the diagnosis of serial herpes simplex virus encephalitisJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group.1989
- Vidarabine versus Acyclovir Therapy in Herpes Simplex EncephalitisNew England Journal of Medicine, 1986
- ACYCLOVIR VERSUS VIDARABINE IN HERPES SIMPLEX ENCEPHALITISThe Lancet, 1984
- Experience with Brain Biopsy for Suspected Herpes Encephalitis: A Review of Forty Consecutive CasesNeurosurgery, 1983